A citation-based method for searching scientific literature

David A Lipson, Frank Barnhart, Noushin Brealey, Jean Brooks, Gerard J Criner, Nicola C Day, Mark T Dransfield, David M G Halpin, MeiLan K Han, C Elaine Jones, Sally Kilbride, Peter Lange, David A Lomas, Fernando J Martinez, Dave Singh, Maggie Tabberer, Robert A Wise, Steven J Pascoe. N Engl J Med 2018
Times Cited: 471







List of co-cited articles
588 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.
Alberto Papi, Jørgen Vestbo, Leonardo Fabbri, Massimo Corradi, Hélène Prunier, Géraldine Cohuet, Alessandro Guasconi, Isabella Montagna, Stefano Vezzoli, Stefano Petruzzelli,[...]. Lancet 2018
262
41

Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
Klaus F Rabe, Fernando J Martinez, Gary T Ferguson, Chen Wang, Dave Singh, Jadwiga A Wedzicha, Roopa Trivedi, Earl St Rose, Shaila Ballal, Julie McLaren,[...]. N Engl J Med 2020
115
41

Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial.
Dave Singh, Alberto Papi, Massimo Corradi, Ilona Pavlišová, Isabella Montagna, Catherine Francisco, Géraldine Cohuet, Stefano Vezzoli, Mario Scuri, Jørgen Vestbo. Lancet 2016
225
27

Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial.
Gary T Ferguson, Klaus F Rabe, Fernando J Martinez, Leonardo M Fabbri, Chen Wang, Masakazu Ichinose, Eric Bourne, Shaila Ballal, Patrick Darken, Kiernan DeAngelis,[...]. Lancet Respir Med 2018
150
25

Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.
Jadwiga A Wedzicha, Donald Banerji, Kenneth R Chapman, Jørgen Vestbo, Nicolas Roche, R Timothy Ayers, Chau Thach, Robert Fogel, Francesco Patalano, Claus F Vogelmeier. N Engl J Med 2016
497
23

Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial.
Jørgen Vestbo, Alberto Papi, Massimo Corradi, Viktor Blazhko, Isabella Montagna, Catherine Francisco, Géraldine Cohuet, Stefano Vezzoli, Mario Scuri, Dave Singh. Lancet 2017
209
23

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
Peter M A Calverley, Julie A Anderson, Bartolome Celli, Gary T Ferguson, Christine Jenkins, Paul W Jones, Julie C Yates, Jørgen Vestbo. N Engl J Med 2007
21

Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease.
David A Lipson, Courtney Crim, Gerard J Criner, Nicola C Day, Mark T Dransfield, David M G Halpin, MeiLan K Han, C Elaine Jones, Sally Kilbride, Peter Lange,[...]. Am J Respir Crit Care Med 2020
59
33

Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline.
Linda Nici, Manoj J Mammen, Edward Charbek, Paul E Alexander, David H Au, Cynthia M Boyd, Gerard J Criner, Gavin C Donaldson, Michael Dreher, Vincent S Fan,[...]. Am J Respir Crit Care Med 2020
103
19

FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease.
David A Lipson, Helen Barnacle, Ruby Birk, Noushin Brealey, Nicholas Locantore, David A Lomas, Andrea Ludwig-Sengpiel, Rajat Mohindra, Maggie Tabberer, Chang-Qing Zhu,[...]. Am J Respir Crit Care Med 2017
166
17

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.
Dave Singh, Alvar Agusti, Antonio Anzueto, Peter J Barnes, Jean Bourbeau, Bartolome R Celli, Gerard J Criner, Peter Frith, David M G Halpin, Meilan Han,[...]. Eur Respir J 2019
667
16

Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial.
Jørgen Vestbo, Julie A Anderson, Robert D Brook, Peter M A Calverley, Bartolome R Celli, Courtney Crim, Fernando Martinez, Julie Yates, David E Newby. Lancet 2016
246
16

Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.
Steven Pascoe, Neil Barnes, Guy Brusselle, Chris Compton, Gerard J Criner, Mark T Dransfield, David M G Halpin, MeiLan K Han, Benjamin Hartley, Peter Lange,[...]. Lancet Respir Med 2019
83
19

Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials.
Mona Bafadhel, Stefan Peterson, Miguel A De Blas, Peter M Calverley, Stephen I Rennard, Kai Richter, Malin Fagerås. Lancet Respir Med 2018
190
15

Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial.
Henrik Watz, Kay Tetzlaff, Emiel F M Wouters, Anne Kirsten, Helgo Magnussen, Roberto Rodriguez-Roisin, Claus Vogelmeier, Leonardo M Fabbri, Pascal Chanez, Ronald Dahl,[...]. Lancet Respir Med 2016
264
14

Inhaled corticosteroids in COPD: friend or foe?
Alvar Agusti, Leonardo M Fabbri, Dave Singh, Jørgen Vestbo, Bartolome Celli, Frits M E Franssen, Klaus F Rabe, Alberto Papi. Eur Respir J 2018
100
14


Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial.
Kenneth R Chapman, John R Hurst, Stefan-Marian Frent, Michael Larbig, Robert Fogel, Tadhg Guerin, Donald Banerji, Francesco Patalano, Pankaj Goyal, Pascal Pfister,[...]. Am J Respir Crit Care Med 2018
126
13

Withdrawal of inhaled glucocorticoids and exacerbations of COPD.
Helgo Magnussen, Bernd Disse, Roberto Rodriguez-Roisin, Anne Kirsten, Henrik Watz, Kay Tetzlaff, Lesley Towse, Helen Finnigan, Ronald Dahl, Marc Decramer,[...]. N Engl J Med 2014
384
13

Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline.
James D Chalmers, Irena F Laska, Frits M E Franssen, Wim Janssens, Ian Pavord, David Rigau, Melissa J McDonnell, Nicolas Roche, Don D Sin, Daiana Stolz,[...]. Eur Respir J 2020
47
27

Susceptibility to exacerbation in chronic obstructive pulmonary disease.
John R Hurst, Jørgen Vestbo, Antonio Anzueto, Nicholas Locantore, Hana Müllerova, Ruth Tal-Singer, Bruce Miller, David A Lomas, Alvar Agusti, William Macnee,[...]. N Engl J Med 2010
12

Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.
Mona Bafadhel, Susan McKenna, Sarah Terry, Vijay Mistry, Carlene Reid, Pranabashis Haldar, Margaret McCormick, Koirobi Haldar, Tatiana Kebadze, Annelyse Duvoix,[...]. Am J Respir Crit Care Med 2011
628
11

Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease.
Salman H Siddiqui, Alessandro Guasconi, Jørgen Vestbo, Paul Jones, Alvar Agusti, Pierluigi Paggiaro, Jadwiga A Wedzicha, Dave Singh. Am J Respir Crit Care Med 2015
252
10

Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.
J J Soler-Cataluña, M A Martínez-García, P Román Sánchez, E Salcedo, M Navarro, R Ochando. Thorax 2005
9

Treatable traits: toward precision medicine of chronic airway diseases.
Alvar Agusti, Elisabeth Bel, Mike Thomas, Claus Vogelmeier, Guy Brusselle, Stephen Holgate, Marc Humbert, Paul Jones, Peter G Gibson, Jørgen Vestbo,[...]. Eur Respir J 2016
492
9

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.
Jadwiga A Wedzicha, Peter M A Calverley, Terence A Seemungal, Gerry Hagan, Zainab Ansari, Robert A Stockley. Am J Respir Crit Care Med 2008
598
9

Inhaled corticosteroid containing combinations and mortality in COPD.
Jørgen Vestbo, Leonardo Fabbri, Alberto Papi, Stefano Petruzzelli, Mario Scuri, Alessandro Guasconi, Stefano Vezzoli, Dave Singh. Eur Respir J 2018
37
24

Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results.
C Crim, P M A Calverley, J A Anderson, B Celli, G T Ferguson, C Jenkins, P W Jones, L R Willits, J C Yates, J Vestbo. Eur Respir J 2009
301
9

Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
MeiLan K Han, Pedro M Quibrera, Elizabeth E Carretta, R Graham Barr, Eugene R Bleecker, Russell P Bowler, Christopher B Cooper, Alejandro Comellas, David J Couper, Jeffrey L Curtis,[...]. Lancet Respir Med 2017
145
9

Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis.
Mario Cazzola, Paola Rogliani, Luigino Calzetta, Maria Gabriella Matera. Eur Respir J 2018
73
12

The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical Trial.
MeiLan K Han, Gerard J Criner, Mark T Dransfield, David M G Halpin, C Elaine Jones, Sally Kilbride, Peter Lange, Sally Lettis, David A Lipson, David A Lomas,[...]. Am J Respir Crit Care Med 2020
15
60

Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers.
Andrew P Yu, Annie Guérin, Diego Ponce de Leon, Karthik Ramakrishnan, Eric Q Wu, Michelle Mocarski, Steve Blum, Juliana Setyawan. J Med Econ 2011
86
10

Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study.
Fernando J Martinez, Klaus F Rabe, Gary T Ferguson, Jadwiga A Wedzicha, Dave Singh, Chen Wang, Kimberly Rossman, Earl St Rose, Roopa Trivedi, Shaila Ballal,[...]. Am J Respir Crit Care Med 2021
32
28

Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD.
Courtney Crim, Mark T Dransfield, Jean Bourbeau, Paul W Jones, Nicola A Hanania, Donald A Mahler, Jørgen Vestbo, Andrew Wachtel, Fernando J Martinez, Frank Barnhart,[...]. Ann Am Thorac Soc 2015
96
8

Benralizumab for the Prevention of COPD Exacerbations.
Gerard J Criner, Bartolome R Celli, Christopher E Brightling, Alvar Agusti, Alberto Papi, Dave Singh, Don D Sin, Claus F Vogelmeier, Frank C Sciurba, Mona Bafadhel,[...]. N Engl J Med 2019
88
9

Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis.
Yayuan Zheng, Jianhong Zhu, Yuyu Liu, Weiguang Lai, Chunyu Lin, Kaifen Qiu, Junyan Wu, Weimin Yao. BMJ 2018
41
19

Triple therapy trials in COPD: a precision medicine opportunity.
Samy Suissa, Amnon Ariel. Eur Respir J 2018
37
21

Evaluating triple ICS/LABA/LAMA therapies for COPD patients: a network meta-analysis of ETHOS, KRONOS, IMPACT, and TRILOGY studies.
Luigino Calzetta, Beatrice Ludovica Ritondo, Patrizia de Marco, Mario Cazzola, Paola Rogliani. Expert Rev Respir Med 2021
12
66

Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease.
Dave Singh, Mona Bafadhel, Christopher E Brightling, Frank C Sciurba, Jeffrey L Curtis, Fernando J Martinez, Cara B Pasquale, Debora D Merrill, Norbert Metzdorf, Stefano Petruzzelli,[...]. Am J Respir Crit Care Med 2020
30
26

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Donald P Tashkin, Bartolome Celli, Stephen Senn, Deborah Burkhart, Steven Kesten, Shailendra Menjoge, Marc Decramer. N Engl J Med 2008
8

Development and first validation of the COPD Assessment Test.
P W Jones, G Harding, P Berry, I Wiklund, W-H Chen, N Kline Leidy. Eur Respir J 2009
8

Azithromycin for prevention of exacerbations of COPD.
Richard K Albert, John Connett, William C Bailey, Richard Casaburi, J Allen D Cooper, Gerard J Criner, Jeffrey L Curtis, Mark T Dransfield, Meilan K Han, Stephen C Lazarus,[...]. N Engl J Med 2011
732
7

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease.
Ian D Pavord, Pascal Chanez, Gerard J Criner, Huib A M Kerstjens, Stephanie Korn, Njira Lugogo, Jean-Benoit Martinot, Hironori Sagara, Frank C Albers, Eric S Bradford,[...]. N Engl J Med 2017
263
7

Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.
Signe Vedel-Krogh, Sune F Nielsen, Peter Lange, Jørgen Vestbo, Børge G Nordestgaard. Am J Respir Crit Care Med 2016
238
7

Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.
Jeong H Yun, Andrew Lamb, Robert Chase, Dave Singh, Margaret M Parker, Aabida Saferali, Jørgen Vestbo, Ruth Tal-Singer, Peter J Castaldi, Edwin K Silverman,[...]. J Allergy Clin Immunol 2018
90
7

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal.
Lowie Vanfleteren, Leonardo M Fabbri, Alberto Papi, Stefano Petruzzelli, Bartolome Celli. Int J Chron Obstruct Pulmon Dis 2018
35
20

Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial.
Peter M A Calverley, Antonio R Anzueto, Kerstine Carter, Lars Grönke, Christoph Hallmann, Christine Jenkins, Jadwiga Wedzicha, Klaus F Rabe. Lancet Respir Med 2018
106
7



Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study.
Jadwiga A Wedzicha, Marc Decramer, Joachim H Ficker, Dennis E Niewoehner, Thomas Sandström, Angel Fowler Taylor, Peter D'Andrea, Christie Arrasate, Hungta Chen, Donald Banerji. Lancet Respir Med 2013
372
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.